VANGUARD GROUP INC - VYNE THERAPEUTICS INC ownership

VYNE THERAPEUTICS INC's ticker is VYNE and the CUSIP is 92941V209. A total of 66 filers reported holding VYNE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.51 and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of VYNE THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$247,591
-32.7%
1,650,607
+0.1%
0.00%
Q3 2022$368,000
-47.4%
1,649,489
-8.4%
0.00%
Q2 2022$700,000
-27.2%
1,800,530
+21.7%
0.00%
Q1 2022$962,000
-58.0%
1,479,926
-34.1%
0.00%
Q4 2021$2,290,000
-32.4%
2,246,231
-7.8%
0.00%
Q3 2021$3,386,000
-60.4%
2,436,4320.0%0.00%
Q2 2021$8,552,000
-49.8%
2,436,432
-2.1%
0.00%
Q1 2021$17,039,0002,489,2610.00%
Other shareholders
VYNE THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
DSC Advisors, L.P. 2,670,000$1,038,0001.04%
DELTEC ASSET MANAGEMENT LLC 30,000$12,0000.00%
Tekla Capital Management LLC 135,395$53,0000.00%
Virtu Financial LLC 64,838$25,0000.00%
TWO SIGMA SECURITIES, LLC 127,844$50,0000.00%
STALEY CAPITAL ADVISERS INC 62,500$24,0000.00%
Beacon Pointe Advisors, LLC 75,000$28,0000.00%
Cetera Advisor Networks LLC 115,000$45,0000.00%
TOBIAS FINANCIAL ADVISORS, INC. 11,000$4,0000.00%
Russell Investments Group, Ltd. 3,375$1,0000.00%
View complete list of VYNE THERAPEUTICS INC shareholders